Abstract: The present invention concerns a method for modulating the enzymatic activity of an enzyme, wherein said enzyme interacts with BMP, said method comprising the step of administering or inducing Hsp70, or a functional fragment or variant thereof, in a form suitable for allowing interaction between BMP and Hsp70, or said functional fragment or variant thereof, and thereby modulating the enzymatic activity of an enzyme interacting with BMP.
Type:
Grant
Filed:
March 7, 2022
Date of Patent:
March 26, 2024
Assignee:
ZEVRA DENMARK A/S
Inventors:
Thomas Kirkegaard Jensen, Marja H. Jaattela
Abstract: The present specification discloses pest control compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a population of invertebrate pests from a mammal, location, plant, structure treated of such pest control compositions.
Abstract: A method of isotope-labelling a microbiota sample. It involves providing a first microbiota sample that was obtained from a given source; exposing the first microbiota sample to an isotope enriched medium; and culturing the exposed first microbiota sample in the isotope enriched medium to obtain an isotope-labelled microbiota sample, wherein the isotope labelled metaproteome of the isotope-labelled microbiota sample is taxon specific for taxa present in the first microbiota sample when initially obtained from the given source.
Type:
Grant
Filed:
January 27, 2021
Date of Patent:
March 19, 2024
Assignee:
UNIVERSITY OF OTTAWA
Inventors:
Joseph Michel Daniel Figeys, Alain Christophe Stintzi, David R. Mack, Xu Zhang, Zhibin Ning
Abstract: The present invention relates to fusion proteins comprising an N-intein polypeptide and an N-intein solubilization partner, and affinity chromatography matrices comprising such fusion proteins, as well as methods of using same.
Abstract: A cardiomyocyte maturation medium comprises a base medium, one or more fatty acids such as palmitic acid, glucose and albumin. The one or more fatty acids and glucose are ideally present at a concentration ratio of about 1:10. Typically, the medium does not comprise TGF or insulin, or comprises minimal TGF and/or insulin. A cell culture vessel is provided that comprises opposed poles that facilitate force measurements of developing cardiac muscle.
Type:
Grant
Filed:
August 25, 2017
Date of Patent:
March 5, 2024
Assignee:
THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
Inventors:
Enzo Porrello, James Hudson, Drew Titmarsh, Richard Mills
Abstract: Provided herein are methods of treating EIPH in a subject in need thereof. The methods comprise administering an effective amount of a pharmaceutical composition to the subject. In some embodiments, the pharmaceutical composition comprises a granuloma fluid, or a composition derived from a granuloma fluid. In some embodiments, the pharmaceutical composition comprises a cell. These pharmaceutical compositions may be administered by any suitable route of administration, and may be administered with one or more further therapeutic agents. Also provided are kits comprising pharmaceutical compositions for use with the methods provided herein.
Abstract: A method of making an electron beam irradiated osteoinductive implant is provided. The method comprises exposing an osteoinductive implant containing demineralized bone matrix (DBM) fibers to electron beam radiation at a dose of from about 10 kilograys to 100 kilograys for a period of time. The electron beam irradiation reduces microorganisms in the osteoinductive implant, and the electron beam irradiated osteoinductive implant retains osteoinductive properties. Methods of implantation and an irradiated osteoinductive implant are also disclosed.
Type:
Grant
Filed:
August 16, 2021
Date of Patent:
March 5, 2024
Assignee:
Warsaw Orthopedic, Inc.
Inventors:
Kelly W. Schlachter, Erick Vasquez, Daniel A. Shimko
Abstract: The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial consortia, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial consortia, and compositions comprising the same, in methods for modulating the production and yield of milk and milk components in ruminants. In particular aspects, the disclosure provides methods of increasing desirable components of milk in ruminants. Furthermore, the disclosure provides for methods of modulating the rumen microbiome.
Type:
Grant
Filed:
February 23, 2022
Date of Patent:
February 27, 2024
Assignee:
Native Microbials, Inc.
Inventors:
Mallory Embree, Luke Picking, Grant Gogul, Janna Tarasova
Abstract: An apparatus and method for detecting an analyte of interest using paper spray mass spectrometry includes a spray material; a sample on the spray material including an enzyme of interest; a solvent to hydrate the sample, promote enzymatic activity, and extract analytes of interest from the sample; a substrate specific to the enzyme of interest, wherein any of the spray material and the solvent includes the substrate; a voltage source to apply a voltage to the spray material to create charged droplets of a mixture containing the sample; and a mass spectrometer to perform spectrometry on the droplets to perform any of: identify the analytes of interest in the sample; and measure a level of inhibition in any enzymes contained in the sample.
Type:
Grant
Filed:
October 26, 2021
Date of Patent:
February 27, 2024
Assignee:
The United States of America as Represented by the Secretary of the Army
Inventors:
Trevor G Glaros, Elizabeth S Dhummakupt, Phillip M Mach, Daniel O Carmany
Abstract: The present disclosure discloses a preparation method for hyperthermophilic aerobic fermentation inoculant prepared by using sewage sludge, the method includes the following steps: carrying out fermentation after the activation of hyperthermophilic aerobic bacteria, removing the supernatant from the fermentation products, and adding the protective agent and stirring until uniform, drying to obtain a product, pulverizing the product by a pulverizer, and sieving the product before sub-packing. The solution of the present disclosure has the following advantages.
Abstract: Herein is reported a method for producing a thymocyte supernatant comprising the steps of co-cultivating thymocytes and mononuclear cells at a cell ratio of at least 0.5:1.2 in the presence of phorbol-12-myristate-13-acetate and Phytohemagglutinin M for up to 60 hours, and separating the co-cultivation medium from the cells and thereby producing the thymocyte supernatant.
Type:
Grant
Filed:
October 2, 2019
Date of Patent:
February 6, 2024
Assignee:
Hoffmann-La Roche Inc.
Inventors:
Sonja Offner, Markus Horvath, Ingried Saam
Abstract: The invention relates to chitin, a hydrolysate and a method for the production of at least one desired product from insects. More specifically, the invention relates to a method for the production of at least one desired product from insects, comprising an insect cuticle pressing step, followed by the enzymatic hydrolysis of the insect cuticles using a proteolytic enzyme.
Type:
Grant
Filed:
December 30, 2015
Date of Patent:
February 6, 2024
Inventors:
Nathalie Berezina, Antoine Hubert, Fabrice Berro, Jean-Gabriel Levon, Karine Le Roux, Cecilia Socolsky, Lorena Sanchez, Sophie Laurent
Abstract: The invention is directed to Haematococcus sp. KAU-01 as well as to a culture medium for Haematococcus sp. KAU-01, and to methods for using this strain to process environmental pollutants such as gases generated by coal-fired plants.
Type:
Grant
Filed:
December 7, 2020
Date of Patent:
January 30, 2024
Assignee:
King Abdulaziz University
Inventors:
Adnan Jaman Turki, Md. Abu Affan, Salim Marzoog Al-Harbi
Abstract: The present invention relates to compositions and methods for increasing the health of aquatic animals comprising one or more selected bacterial strains.
Type:
Grant
Filed:
April 9, 2014
Date of Patent:
January 30, 2024
Assignee:
Novozymes A/S
Inventors:
David Drahos, Christian Munch, Lene Venke Kofod
Abstract: The invention relates to a biological indicator for determining the efficacy of a steam or heat sterilization process, and its method. The biological indicator comprises microbial spores (a), at least one sensor protein exogenous to the microbial spores (b), one fluorophore (c), and a culture medium (d). The invention also refers to the method of use of this biological indicator.
Type:
Grant
Filed:
August 16, 2019
Date of Patent:
January 30, 2024
Assignees:
Terragene LLC, Terragene SA
Inventors:
Adrian Jesus Rovetto, Esteban Lombardia, Pablo Ravasi
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said glycan therapeutics, e.g. in cancer therapy.
Type:
Grant
Filed:
June 30, 2021
Date of Patent:
January 30, 2024
Assignee:
DSM Nutritional Products, LLC
Inventors:
Geoffrey A. von Maltzahn, Yvonne J. Yamanaka, Jared Silverman, John Miles Milwid, Jacob Rosenblum Rubens, John M. Geremia
Abstract: A method of screening for a substance that acts on a cell mass includes producing a cell mass by three-dimensional culture of primary cancer cells using a tumor tissue, adding a test substance to the cell mass, and evaluating an action of the test substance on the cell mass. The cell mass is produced by culturing cells obtained from the tumor tissue in a medium containing a 5% v/v or less extracellular matrix on a substantially low-adhesive cell culture substrate and producing the cell mass of the primary cancer cells.
Abstract: A method of dissociating single cells from a biological tissue sample is described herein, along with systems for performing such methods. The method includes generating one or more ultrasonic wave pulses using a transducer comprising one or more Fresnel Annular Sector Actuator (FASA) elements; and applying energy from the generated one or more ultrasonic wave pulses to a sample container holding the biological tissue sample through a coupling medium that couples the one or more FASA elements to the sample container to dissociate single cells from the biological tissue is described herein.
Abstract: The present invention provides method for treating a metabolic disorder, dietary intolerance, or malabsorption in a subject that causes an excess of a metabolite or a dietary substance, particularly a carbohydrate such as galactose or fructose, that the subject does not tolerate by administering an effective amount of an adaptively evolved yeast strain to the subject or to food that reduces the excess of the metabolite or dietary substance. Specifically, the invention is directed to methods for treating the metabolic disorder, such as galactosemia or fructosemia, in which an excess of the carbohydrate is present. The invention also provides isolated, adaptively evolved yeast strains that degrades a metabolite or dietary ingredient, such as galactose or fructose, and methods for preparing such isolated, adaptively evolved yeast strains.
Abstract: The present invention relates to a newly isolated bacterium belonging to the genus Microbacterium, a composition for producing psicose comprising the strain, and a method for producing psicose using the same.
Type:
Grant
Filed:
December 26, 2017
Date of Patent:
January 2, 2024
Assignee:
SAMYANG CORPORATION
Inventors:
Bu-Soo Park, Eun Jin Han, Sang-Hee Lee, Soun Gyu Kwon, Jin Ha Kim, Chong Jin Park